| 25 |
Agreement for joint research between LyseNTech and Zoonotic Infectious Disease Research Institute of Chonbuk National University |
LyseNTech |
2024-05-27 |
2184 |
| 24 |
Approval of IND for phase I clinical trial for Endolysin LNT103 |
LyseNTech |
2024-04-03 |
2301 |
| 23 |
LyseNTech selected for the GloPID-R project |
LyseNTech |
2024-04-03 |
2315 |
| 22 |
LyseNTech filed IND for phase 1 clinical trial of its endolysin |
LyseNTech |
2023-11-23 |
2377 |
| 21 |
LyseNTech acquired US patent for endolysin LNT103 |
LyseNTech |
2023-11-22 |
2276 |
| 20 |
LyseNTech won the grand prize at the 2023 Gyeonggi Startup Investment Conference & Global Day |
LyseNTech |
2023-11-03 |
2319 |
| 19 |
Heejoon Myung, CEO of LyseNTech, presented at the 2023 Korean Society of Infectious Diseases |
LyseNTech |
2023-11-03 |
2318 |
| 18 |
Poster presentation in World AMR Congress 2023 (Philadelphia, USA) |
LyseNTech |
2023-09-21 |
2314 |
| 17 |
Oral presentation in The 1st International Symposium for Infectious Diseases Research Institutes Cooperation |
LyseNTech |
2023-09-21 |
2387 |
| 16 |
Oral presentation in 26th Congress of the Asian Pacific Society of Respirology |
LyseNTech |
2023-09-21 |
2374 |
